Please login to the form below
Therapy Watch expands its oncology portfolio
This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio which covers Chronic Lymphocytic Leukaemia (CLL), Non-Hodgkin's Lymphoma (NHL), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer (PCa), Renal Cell Carcinoma.
Find out more: http://www.researchpartnership.com/news/2016/10/therapy-watch-expands-oncology-portfolio/
Company Details
Research Partnership
+44 (0)20 8069 5000
Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom
Latest content on this profile
- EphMRA Annual Conference 2018
- Visit us on stand number 20
Research Partnership
- Live from Singapore: Full speed ahead - Unlock the full potential of your brand tracking
- Thursday 28th June 16:00 SGT/ 16:00 CST / 17:00 JST
Research Partnership
- Connected Patients - Adopting a patient-centric approach in emerging markets
Research Partnership
- Combination therapies in oncology: The benefits of integrated insights
- 14 June 2018
11am EDT | 8am PDT | 4pm BST | 5pm CE
Research Partnership
- Intellus round up 2018
- Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia
Research Partnership
- Janssen & Research Partnership win prestigious BHBIA Best Business Impact award
Research Partnership
- About us
- Contact us
- How to advertise
- Site map
- All content copyright © PMGroup Worldwide Ltd 2018
